600 Saginaw Dr
Redwood City, CA 94063-4751
CardioDx is a personalized medicine company that develops and commercializes genetic based cardiac diagnostic tests. The company is currently developing several molecular diagnostics that will help physicians determine appropriate treatment for cardiovascular patients. CardioDx is using both genetics and genomics technologies to develop these unique diagnostic products. The company was formed in 2004 and is funded by Kleiner, Perkins, Caufield, and Byers, TPG Ventures, Mohr Davidow Ventures, and Intel Capital.